0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Image of the Month—Quiz Case FREE

Raul Jiménez, MD; Adolfo Beguiristain, MD, PhD; Inmaculada Ruiz-Montesinos, MD; Francisco Villar, MD; Miguel A. Medrano, MD; Francisco Garnateo, MD; Manuel Vaquero, MD; Miguel Echenique Elizondo, MD, PhD
[+] Author Affiliations

Deceased.


Section Editor: Carl E. Bredenberg, MD


Arch Surg. 2008;143(8):805. doi:10.1001/archsurg.143.8.805.
Text Size: A A A
Published online

A 34-year-old woman, who was using contraceptive therapy and had no previous severe illness recorded, had a hypodense lesion on segment 6 of the liver during a routine ultrasonography examination. Physical examination results were unremarkable. Blood and liver function test results and α-fetoprotein, carcinoembryonic antigen, and cancer antigen 19-9 levels were within normal limits. Viral hepatitis serologic test results and antimitochondrial antibody levels were unavailable. A chest radiograph and whole-body bone scan showed no evidence of metastases. A computed tomography–guided needle core biopsy revealed a chronic inflammatory infiltrate. Magnetic resonance imaging showed a hyperintense T2 signaling nodular lesion and arterial phase enhancement with gadolinium injection (Figure 1). The hepatic lesion was surgically resected. The patient's postoperative course was uneventful. Grossly, the resected liver segment contained a well-circumscribed, tan, nonencapsulated, solitary nodule of rubbery consistency, measuring 2.7 × 2.0 × 1.9 cm. Microscopically, the hepatic mass was composed of polymorphic small lymphocytes forming prominent lymphoid follicles with germinal centers of varying size, containing tingible body macrophages (Figure 2). Mitoses were infrequent. No bile ducts were involved in the nodular lesion. The remainder of the resected liver parenchyma was unremarkable. Immunostaining demonstrated B lymphocytes in the follicles (CD20 and Bcl-6 positive; Bcl-2 negative) along with T lymphocytes (CD3 positive). Plasma cells were positive for κ and λ chains at a 3:1 ratio.

Place holder to copy figure label and caption
Figure 1.

Magnetic resonance imaging showed a hyperintense T2 signaling nodular lesion and arterial phase enhancement with gadolinium injection.

Graphic Jump Location

Place holder to copy figure label and caption
Figure 2.

Microscopically, the hepatic mass was composed of polymorphic small lymphocytes forming prominent lymphoid follicles with germinal centers of varying size, containing tingible body macrophages.

Graphic Jump Location

WHAT IS THE DIAGNOSIS?

A. Hepatic hemangioma

B. Reactive lymphoid hyperplasia

C. Primary liver adenoma

D. Liver metastasis from gastrointestinal tract neoplasm

Figures

Place holder to copy figure label and caption
Figure 1.

Magnetic resonance imaging showed a hyperintense T2 signaling nodular lesion and arterial phase enhancement with gadolinium injection.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Microscopically, the hepatic mass was composed of polymorphic small lymphocytes forming prominent lymphoid follicles with germinal centers of varying size, containing tingible body macrophages.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
JAMAevidence.com